CU 104
Alternative Names: CU-104Latest Information Update: 20 Dec 2023
At a glance
- Originator CURACLE
- Class Anti-inflammatories
- Mechanism of Action Interleukin 1 beta inhibitors; Interleukin 6 inhibitors; Tumour necrosis factor alpha inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase I Ulcerative colitis